| Encyclopedia of Pharmaceutical Technology: Volume 6 J Swarbrick CRC press, 2013 | 1739 | 2013 |
| Chemistry and structural biology of androgen receptor W Gao, CE Bohl, JT Dalton Chemical reviews 105 (9), 3352-3370, 2005 | 681 | 2005 |
| Structural basis for antagonism and resistance of bicalutamide in prostate cancer CE Bohl, W Gao, DD Miller, CE Bell, JT Dalton Proceedings of the National Academy of Sciences 102 (17), 6201-6206, 2005 | 493 | 2005 |
| Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia JC Byrd, TS Lin, JT Dalton, D Wu, MA Phelps, B Fischer, M Moran, ... Blood 109 (2), 399-404, 2007 | 460 | 2007 |
| The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double … JT Dalton, KG Barnette, CE Bohl, ML Hancock, D Rodriguez, ST Dodson, ... Journal of cachexia, sarcopenia and muscle 2, 153-161, 2011 | 420 | 2011 |
| Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial AS Dobs, RV Boccia, CC Croot, NY Gabrail, JT Dalton, ML Hancock, ... The lancet oncology 14 (4), 335-345, 2013 | 403 | 2013 |
| Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies S Dodson, VE Baracos, A Jatoi, WJ Evans, D Cella, JT Dalton, MS Steiner Annual review of medicine 62 (1), 265-279, 2011 | 399 | 2011 |
| Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging S Bhasin, OM Calof, TW Storer, ML Lee, NA Mazer, R Jasuja, VM Montori, ... Nature clinical practice Endocrinology & metabolism 2 (3), 146-159, 2006 | 372 | 2006 |
| Discovery of nonsteroidal androgens JT Dalton, A Mukherjee, Z Zhu, L Kirkovsky, DD Miller Biochemical and biophysical research communications 244 (1), 1-4, 1998 | 297 | 1998 |
| Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs) W Gao, JT Dalton Drug discovery today 12 (5-6), 241-248, 2007 | 273 | 2007 |
| Favorable effects of weak acids on negative-ion electrospray ionization mass spectrometry Z Wu, W Gao, MA Phelps, D Wu, DD Miller, JT Dalton Analytical chemistry 76 (3), 839-847, 2004 | 256 | 2004 |
| Structural basis for accommodation of nonsteroidal ligands in the androgen receptor CE Bohl, DD Miller, J Chen, CE Bell, JT Dalton Journal of biological chemistry 280 (45), 37747-37754, 2005 | 253 | 2005 |
| Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit ML Mohler, CE Bohl, A Jones, CC Coss, R Narayanan, Y He, DJ Hwang, ... Journal of medicinal chemistry 52 (12), 3597-3617, 2009 | 248 | 2009 |
| Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9* 3 allele RS Kidd, AB Straughn, MC Meyer, J Blaisdell, JA Goldstein, JT Dalton Pharmacogenetics and Genomics 9 (1), 71-80, 1999 | 238 | 1999 |
| Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer V Gududuru, E Hurh, JT Dalton, DD Miller Bioorganic & medicinal chemistry letters 14 (21), 5289-5293, 2004 | 237 | 2004 |
| Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats W Gao, PJ Reiser, CC Coss, MA Phelps, JD Kearbey, DD Miller, ... Endocrinology 146 (11), 4887-4897, 2005 | 233 | 2005 |
| Development of selective androgen receptor modulators (SARMs) R Narayanan, CC Coss, JT Dalton Molecular and cellular endocrinology 465, 134-142, 2018 | 232 | 2018 |
| Pharmacodynamics of selective androgen receptor modulators D Yin, W Gao, JD Kearbey, H Xu, K Chung, Y He, CA Marhefka, ... Journal of Pharmacology and Experimental Therapeutics 304 (3), 1334-1340, 2003 | 223 | 2003 |
| Selective androgen receptor modulators in preclinical and clinical development R Narayanan, ML Mohler, CE Bohl, DD Miller, JT Dalton Nuclear receptor signaling 6 (1), nrs. 06010, 2008 | 212 | 2008 |
| Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, biological evaluation, and structure− activity relationships Y Lu, CM Li, Z Wang, CR Ross, J Chen, JT Dalton, W Li, DD Miller Journal of medicinal chemistry 52 (6), 1701-1711, 2009 | 208 | 2009 |
